Chitosan Loaded Mucoadhesive Microspheres of Gliclazide - Journal

Table 3: Comparison of severity of symptoms
Change in Symptoms Treatment
Azithromycin + Azithromycin + Azithromycin + P value
Ceftriaxone Cefotaxime Cefuroxime
Baseline Sputum Production
Severe 84.4 83.7 84.6
Mild/Moderate 12.5 9.3 0.0 0.458
Absent
Day 7
3.1 7.0 15.4
Severe 43.8 25.6 46.2
Mild/Moderate 9.4 0.0 30.8 0.003
Absent 25.0 39.5 15.4
Baseline Cough
Severe 81.2 88.4 84.6
Mild/Moderate 6.2 7.0 0.0 0.574
Absent
Day 7
12.5 4.7 15.4
Severe 40.6 18.6 53.8
Mild/Moderate 12.5 23.3 23.1 0.129
Absent 25.0 23.3 15.4
Wheezing Baseline
Severe 46.9 62.8 61.5
Mild/Moderate 12.5 11.6 23.1 0.364
Absent
Day 7
40.6 25.6 15.4
Severe 9.4 0.0 23.1
Mild/Moderate 18.8 14.0 23.1 0.060
Absent 50.0 51.2 46.2
Dyspnea Baseline
Severe 25.0 30.2 53.8
Mild/Moderate 50.0 39.5 30.8 0.368
Absent
Day 7
25.0 30.2 15.4
Severe 6.2 0.0 21.3
Mild/Moderate 3.12 16.3 46.2 0.006
Absent 40.6 48.8 23.1
Fever Baseline
Observed 37.5 37.2 61.5
Not observed
Day 7
62.5 62.8 38.5 0.261
Observed 21.9 11.6 38.5 0.131
Not observed 56.2 53.5 53.8
Color of Sputum Baseline
Observed 75.0 79.1 76.9 0.917
Not observed
Day 7
25.0 20.9 23.1
Observed 37.5 18.6 61.5 0.039
Not observed 40.6 46.5 30.8
Patients
Discharged (%)
21.9 34.9 7.7 –
P a t i e n t s %
Imran Ahmad Khan et al./ Assessment of Various Combination of Drugs Used In Treatment of Lower Respiratory Tract Infection
144
RJPS, Jul - Sep, 2011/ Vol 1/ Issue 2